J&J’s two-dose Ebola vax regimen safe: Study

London, Sep 15 (IANS) The two-dose vaccine against Ebola virus developed by US drug maker Johnson and Johnson is safe, well tolerated and produces a strong immune response in people over the age of o...

Become a proud member of 1947.com to access this content.